Business Alignment PCL

Business Alignment PCL EBITDA Growth YoY

The Year-over-Year EBITDA Growth of Business Alignment PCL (BIZ.BK) as of Nov 5, 2026 is 37.79 %. In the previous year, Year-over-Year EBITDA Growth was 7.72 % — a change of 389.34% (higher).

EBITDA Growth YoY

37.79 %

YoY

389.34%

Last updated:

Year-over-Year EBITDA Growth of Business Alignment PCL is 2025 37.79 % . Year-over-Year EBITDA Growth of Business Alignment PCL was 2024 7.72 % . It decreases by 389.34% higher compared to the previous year.

The Business Alignment PCL EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2018
89.20 THB
Jan 1, 2019
15.70 THB
Jan 1, 2020
-39.19 THB
Jan 1, 2021
686.06 THB
Jan 1, 2022
-67.11 THB
Jan 1, 2023
45.53 THB
Jan 1, 2024
7.72 THB
Jan 1, 2025
37.79 THB
The Business Alignment PCL EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
37.79 %+389.34%
7.72 %-83.04%
45.53 %-167.84%
-67.11 %-109.78%
686.06 %-1,850.43%
-39.19 %-349.63%
15.70 %-82.40%
89.20 %-331.25%
-38.57 %-121.68%
177.93 %-406.96%
-57.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Business Alignment PCL Stock analysis

What does Business Alignment PCL do? Business Alignment PCL generates revenue through the distribution and installation of medical equipment for cancer treatment via radiotherapy. The company operates in two segments: Sales of medical equipment, which encompasses installation, building construction for equipment placement, repair, maintenance, and efficiency enhancement services, and Hospital operations, focused on cancer treatment. Its primary customers include university-affiliated hospitals, cancer hospitals, the Ministry of Public Health, other government hospitals, healthcare agencies, and private hospitals. The Sales of medical equipment segment serves clients requiring installation and maintenance of radiotherapy equipment, while the Hospital operations segment provides specialized cancer treatment services. Revenue streams are derived from equipment sales, installation, building construction, repair, maintenance, and efficiency improvements for medical equipment, as well as from hospital treatment services for cancer patients. Business Alignment PCL's business model relies on long-term contracts with government and private healthcare institutions for equipment installation and hospital services. The company's revenue is directly tied to the demand for cancer treatment infrastructure and services in Thailand's healthcare sector, with no mention of external partners or additional revenue streams beyond the described segments. Business Alignment PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Business Alignment PCL stock

Year-over-Year EBITDA Growth of Business Alignment PCL is 37.79 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Business Alignment PCL since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Business Alignment PCL historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Business Alignment PCL

All Key Metrics — Business Alignment PCL